Table 1 The mean (± standard deviation) age and number of ranibizumab injections in each treatment schedule group
Treatment schedule | No. injections | |||
|---|---|---|---|---|
During the third year | Age | During the first year including three monthly injections | During the second year | During the third year |
All eyes (n = 128) | 73 (8) | 4.2 (1.3) | 2.2 (1.9) | 3.9 (4.1) |
As-needed- injections determined by quarterly examination schedule | ||||
(n = 28) | 73 (8) | 4.3 (1.6) | 0.6 (0.9) | 1.0 (0.9) |
As-needed injections determined by monthly examinations schedule | ||||
(n = 61) | 71 (8) | 4.0 (1.2) | 1.5 (0.9) | 1.8 (1.1) |
Monthly injection schedule (n = 18) | 75 (8) | 4.3 (1.8) | 5.5 (0.8) | 11.4 (0.7) |
Treat-and-extend schedule (n = 21) | 78 (7) | 4.6 (1.0) | 3.8 (0.6) | 6.4 (2.4) |